The company exhibits severe financial distress, highlighted by a Piotroski F-Score of 1/9, indicating critical weakness in fundamental health. This is compounded by negative revenue growth (-21.10% YoY) and significant profitability losses, with an ROE of -46.69%. Despite maintaining a healthy current ratio of 2.65 and low debt, the technical trend is overwhelmingly bearish with a 71.5% price decline over the last year. The absence of a Graham Number or Intrinsic Value suggests a lack of fundamental support for the current share price.